The Mycobacteriophage Ms6 Lysb N-Terminus Displays Peptidoglycan Binding Affinity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Properties of a Genetically Unique Mycobacteriophage Amanda K
Western Kentucky University TopSCHOLAR® Masters Theses & Specialist Projects Graduate School Spring 2019 Properties of a Genetically Unique Mycobacteriophage Amanda K. Staples Follow this and additional works at: https://digitalcommons.wku.edu/theses Part of the Environmental Microbiology and Microbial Ecology Commons, Microbial Physiology Commons, Other Microbiology Commons, and the Virology Commons This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by an authorized administrator of TopSCHOLAR®. For more information, please contact [email protected]. PROPERTIES OF A GENETICALLY UNIQUE MYCOBACTERIOPHAGE A Thesis Presented to The Faculty of the Department of Biology Western Kentucky University Bowling Green, Kentucky In Partial Fulfillment Of the Requirements for the Degree Master of Science By Amanda K. Staples May 2019 I dedicate this thesis to my sons, Donovan and Dresden Staples. Life is filled with good times and bad times. I wish you both all the strength and wisdom to face the challenges that come your way. Learn and grow from everything and everyone. Always listen to your heart and don’t be afraid to take the road less traveled. Never forget how much I love you both. ACKNOWLEDGMENTS I would like to take the opportunity to express my profound gratitude to all those who contributed to the support and guidance vital in completing this research. Though I am not able to thank all the caring people involved, their assistance has been invaluable. First and foremost, I must pay homage to my family, beginning with my mom. Without her, I would not be able to manage the majority of the chaos surrounding my life. -
S1 Sulfate Reducing Bacteria and Mycobacteria Dominate the Biofilm
Sulfate Reducing Bacteria and Mycobacteria Dominate the Biofilm Communities in a Chloraminated Drinking Water Distribution System C. Kimloi Gomez-Smith 1,2 , Timothy M. LaPara 1, 3, Raymond M. Hozalski 1,3* 1Department of Civil, Environmental, and Geo- Engineering, University of Minnesota, Minneapolis, Minnesota 55455 United States 2Water Resources Sciences Graduate Program, University of Minnesota, St. Paul, Minnesota 55108, United States 3BioTechnology Institute, University of Minnesota, St. Paul, Minnesota 55108, United States Pages: 9 Figures: 2 Tables: 3 Inquiries to: Raymond M. Hozalski, Department of Civil, Environmental, and Geo- Engineering, 500 Pillsbury Drive SE, Minneapolis, MN 554555, Tel: (612) 626-9650. Fax: (612) 626-7750. E-mail: [email protected] S1 Table S1. Reference sequences used in the newly created alignment and taxonomy databases for hsp65 Illumina sequencing. Sequences were obtained from the National Center for Biotechnology Information Genbank database. Accession Accession Organism name Organism name Number Number Arthrobacter ureafaciens DQ007457 Mycobacterium koreense JF271827 Corynebacterium afermentans EF107157 Mycobacterium kubicae AY373458 Mycobacterium abscessus JX154122 Mycobacterium kumamotonense JX154126 Mycobacterium aemonae AM902964 Mycobacterium kyorinense JN974461 Mycobacterium africanum AF547803 Mycobacterium lacticola HM030495 Mycobacterium agri AY438080 Mycobacterium lacticola HM030495 Mycobacterium aichiense AJ310218 Mycobacterium lacus AY438090 Mycobacterium aichiense AF547804 Mycobacterium -
Numerical Analysis of Rapidly Growing, Scotochromogenic Mycobacteria, Including Mycobacterium O Buense Sp
INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, July 1981, p. 263-275 Vol. 31, No. 3 0020-7713/81/030263-13$02.00/0 Numerical Analysis of Rapidly Growing, Scotochromogenic Mycobacteria, Including Mycobacterium o buense sp. nov., norn. rev., Mycobacterium rhodesiae sp. nov., nom. rev., Mycobacterium aichiense sp. nov., norn. rev., Mycobacterium chubuense sp. nov., norn. rev., and Mycobacterium tokaiense sp. nov., nom. rev. MICHIO TSUKAMURA, SHOJI MIZUNO, AND SUM10 TSUKAMURA The National Chubu Hospital, Obu, Aichi, Japan 474 We performed numerical analyses of 155 strains of rapidly growing, scotochrom- ogenic mycobacteria by two different methods; in one method we used 104 characters, and in the other we used 84 characters. The following taxa appeared as distinct clusters: Myco bacterium thermoresistibile, Myco bacterium flavescens, Mycobacterium duvalii, Mycobacterium phlei, “Mycobacterium o buense,” My- co bacterium parafortuitum, Mycobacterium vaccae, Mycobacterium sphagni, “Mycobacterium aichiense,” “Mycobacterium rhodesiae,” Mycobacterium neoaurum, “Mycobacterium chubuense,” “Mycobacterium tokaiense,” and My- cobacterzum komossense (names in quotation marks are not on the Approved Lists of Bacterial Names). M. flavescens strains were divided into two subgroups, one consisting of strains isolated in Japan and the other consisting of strains isolated in Rhodesia and strains received from the American Type Culture Collection, including the type strain of M. flavescens (ATCC 14474). We found that there are many species of rapidly growing, scotochromogenic mycobacteria, and we believe that new species should be recognized and named on the basis of at least three strains. The following species appeared to be distinct from all presently named species: “Mycobacteriumgallinarum,” “Mycobacterium armen- tun,” “Mycobacterium pelpallidurn,” and “Mycobacterium taurus.” However, each of these species was proposed on the basis of only one or two strains. -
Role of Immunotherapy in the Treatment of Tuberculosis
ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF TUBERCULOSIS MURTHY, K.J.R. VIJAYA LAKSHMI, V. and Singh, S. Bhagwan Mahavir Medical Research Centre, 10-1-1, Mahavir Marg, Hyderabad - 500 029. India. ABSTRACT Tuberculosis is caused by Mycobacterium tuberculosis, an intracellular pathogen residing in macrophages. Cell mediated immune (CMI) and delayed type of hypersensitive (DTH) responses play a pivotal role in providing protection to the host. The most important cell is the CD4 T lymphocyte, which is divided into TH1 and TH2 subsets depending on the type of cytokines produced. TH1 cells produce the cytokines interferon-gamma and interleukin-2, which are important for activa- tion of antimycobacterial activities and essential for the DTH response. Grange opines that the immune response in an individual with tuberculous infection gets locked in' to one or other pattern of response viz. TH1 or TH2 response, the latter response leading to tissue damage and progression of disease. Stanford and co-workers conducted several studies on the effectiveness of Mycobacterium vaccae, as an immunotherapeutic agent for tuberculosis. It is non-pathogenic in humans and is thought to be a powerful TH1 adjuvant. A series of small studies pointed that M. vaccae has a beneficial effect and there is enough evidence now to show that its use as an immunotherapeutic agent, as an adjunct to chemotherapy in the treatment of tuberculosis especially at a time when drug resistance is rampant, appears promising. KEY WORDS : Tuberculosis, Drug-Resistance, Immunotherapy, T Cell Responses. ROLE OF IMMUNOTHERAPY IN THE cytokines secreted by the TH1 cell are interferon- TREATMENT OF TUBERCULOSIS gamma (IFN-~,) and interleukin-2 (IL-2). -
Opportunist Mycobacteria
Thorax: first published as 10.1136/thx.44.6.449 on 1 June 1989. Downloaded from Thorax 1989;44:449454 Editorial Treatment of pulmonary disease caused by opportunist mycobacteria During the early 1950s it was recognised that recommended that surgical treatment for opportunist mycobacteria other than Mycobacterium tuberculosis mycobacterial infection should be given to those could cause pulmonary disease in man.' Over 30 years patients who are suitable surgical candidates.'7 The later there is no general agreement about the treatment failure of chemotherapy was often attributed to drug of patients with these mycobacterial infections. The resistance,'2 18 but the importance of prolonging the greatest controversy surrounds the treatment of in- duration of chemotherapy in opportunist mycobac- fection caused by the M aviwn-intracellulare- terial disease beyond that which would normally be scrofulaceum complex (MAIS), for which various required in tuberculosis was not appreciated. In treatments have been advocated, including chemo- several surgically treated series preoperative chemo- therapy with three23 or more' drugs or, alternatively, therapy was given on average for only four to seven surgical resection of the affected lung.78 Although the months,'3 19-22 some patients receiving as little as eight treatment of infection caused by M kansasii is less weeks of treatment before surgery.2324 In contrast, controversial there is no uniform approach to treat- chemotherapy alone, with isoniazid, p-aminosalicyclic ment. Disease caused by M xenopi has been described acid, and streptomycin for 24 months, produced by some as easy to treat with chemotherapy,9 whereas successful results in 80-100% of patients with M others have found the response to drug treatment to be kansasii infection despite reports of in vitro resistance unpredictable.'' " to these agents.2125 This diversity ofopinion and approach to treatment has arisen for two reasons. -
Mycobacterium Goodii Endocarditis Following Mitral Valve Ring Annuloplasty Rohan B
Parikh and Grant Ann Clin Microbiol Antimicrob (2017) 16:14 DOI 10.1186/s12941-017-0190-4 Annals of Clinical Microbiology and Antimicrobials CASE REPORT Open Access Mycobacterium goodii endocarditis following mitral valve ring annuloplasty Rohan B. Parikh1 and Matthew Grant2* Abstract Background: Mycobacterium goodii is an infrequent human pathogen which has been implicated in prosthesis related infections and penetrating injuries. It is often initially misidentified as a gram-positive rod by clinical microbio- logic laboratories and should be considered in the differential diagnosis. Case presentation: We describe here the second reported case of M. goodii endocarditis. Species level identification was performed by 16S rDNA (ribosomal deoxyribonucleic acid) gene sequencing. The patient was successfully treated with mitral valve replacement and a prolonged combination of ciprofloxacin and trimethoprim/sulfamethoxazole. Conclusion: Confirmation of the diagnosis utilizing molecular techniques and drug susceptibility testing allowed for successful treatment of this prosthetic infection. Keywords: Mycobacterium goodii, Endocarditis, Gene sequencing, Prostheses related infections Background appreciated at the apex, and a drain was in place for a Mycobacterium goodii is a rapidly growing non-tubercu- groin seroma related to recent left heart catheterization. lous mycobacterium (NTM) belonging to the Mycobac- He had an unsteady gait and exhibited mild left lower terium smegmatis [1] group. Its importance has become extremity weakness (4/5). His brain magnetic resonance increasingly appreciated as a pathogen over the last imaging showed multiple ring-enhancing lesions in the 20 years, with a predilection towards infecting tissues at pons and posterior fossa suggestive of septic emboli. the site of penetrating injuries. Antibacterial treatment Transthoracic echocardiography showed moderate strategies against this pathogen are diverse but reported mitral regurgitation without any vegetation. -
Immunotherapy of TB…
Results from Phase III, placebo-controlled, 2:1 randomized, double-blind trial of tableted TB vaccine (V7) containing 10 μg of heat-killed Mycobacterium vaccae administered daily for one month Correspondence: Aldar Bourinbaiar * Tel: +976 95130306; +1 301 476-0930 * e-mail: [email protected] Tuberculosis • 33% of people carry TB bacteria = 2.5 billion • Every second, a person becomes ill with TB • Every year 10 mln people develop TB and 2 mln die • Drug-resistant TB poised to become global pandemic • Less than 3% of drug-resistant TB is treated today Th-1 cells = IFN-ɣ, IL-2, GM-CSF, IFN-ɑ, TNF-ɑ, IL-12, IL-18 Th-2 cells = IL-4, IL-5, IL-13 Th-17 cells = IL-6, IL-17, IL-22, TNF-ɑ Treg cells = IL-10, TGF-ɓ B cells = IFN-ɑ, IL-1ɓ, IL-12 Monocytes = IL-8, IL-18, TNF-ɑ State-of-the-art: immunology of TB – a great deal of information gathered but… can't see the forest through the trees When this vast knowledge was applied to immunotherapy of TB…. it failed… It also resulted in negative attitude toward immunotherapy • IL-2 (increased bacterial load) • IL-12 (no effect) • GM-CSF (clearance not confirmed) • IFN-ɣ (irreproducible, no effect) • IFN-ɑ (negative outcome) • anti-TNF-ɑ (negative outcome) • Thalidomide (negative outcome) • Corticosteroids (irreproducible, negative effect) Paradoxes of Tuberculosis • 1/3 of world population (~2.5bln) have latent M. tuberculosis • Yet only about 10 Million people (0.004%) develop TB • M. tuberculosis is in symbiotic relationship with the host • In some cases it’s even beneficial (asthma, cancer) • M. -
An Abstract of the Dissertation of Melanie J. Harriff
AN ABSTRACT OF THE DISSERTATION OF MELANIE J. HARRIFF for the degree of Doctor of Philosophy in Molecular and Cellular Biology presented on June 8, 2007. Title: Mechanisms for the Interaction of Environmental Mycobacteria with Host Cells Abstract approved: Luiz E. Bermudez Michael L. Kent Environmental mycobacteria are important opportunistic pathogens for many hosts, including humans, cattle, and fish. Two well-studied species are Mycobacterium avium subsp. avium, a significant cause of disseminated bacterial disease in patients with AIDS, and Mycobacterium avium subsp. paratuberculosis, the cause of Johne’s disease in cattle. Many other species that are considerable sources of infections in fish, such as Mycobacterium chelonae and Mycobacterium marinum, also have zoonotic potential. To gain knowledge about the invasion of epithelial cells by environmental mycobacteria, selected genes and proteins involved in the uptake of M. avium by HEp-2 cells were analyzed by a variety of methods. Two transcriptional regulators (MAV_3679 and MAV_5138) were identified as being involved in invasion. A mycobacterial protein (CipA) with an amino acid sequence suggestive of an ability to be a part of the scaffolding complex that forms during cell signaling leading to actin polymerization was found to putatively interact with host cell Cdc42. Fusion of CipA to GFP, expressed in Mycobacterium smegmatis, revealed that CipA localizes to a structure on the surface of bacteria approaching HEp-2 cells. To establish whether species of environmental mycobacteria isolated from different hosts use similar mechanisms to M. avium for interaction with the mucosa, and for survival in macrophages, assays to determine invasion and replication were performed in different cell types, and a custom DNA microarray containing probes for known mycobacterial virulence determinants was developed. -
Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes
International Journal of Molecular Sciences Article Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes Adel Abouhmad 1,2 , Ahmed H. Korany 3 , Carl Grey 1, Tarek Dishisha 4 and Rajni Hatti-Kaul 1,* 1 Division of Biotechnology, Department of Chemistry, Center for Chemistry and Chemical Engineering, Lund University, P.O. Box 124, SE-22100 Lund, Sweden; [email protected] (A.A.); [email protected] (C.G.) 2 Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt 3 Department of Microbiology and Immunology, Faculty of Pharmacy, Nahda University, Beni-Suef 62513, Egypt; [email protected] 4 Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt; [email protected] * Correspondence: [email protected]; Tel.: +46-462-224-840 Received: 30 March 2020; Accepted: 28 April 2020; Published: 30 April 2020 Abstract: Mycobacteriophages possess different sets of lytic enzymes for disruption of the complex cell envelope of the mycobacteria host cells and release of the viral progeny. Lysin B (LysB) enzymes are mycolylarabinogalactan esterases that cleave the ester bond between the arabinogalactan and mycolic acids in the mycolylarabinogalactan-peptidoglycan (mAGP) complex in the cell envelope of mycobacteria. In the present study, four LysB enzymes were produced recombinantly and characterized with respect to their enzymatic and antibacterial activities. Examination of the kinetic parameters for the hydrolysis of para-nitrophenyl ester substrates, shows LysB-His6 enzymes to be active against a range of substrates (C4–C16), with a catalytic preference towards p-nitrophenyl laurate (C12). -
Mycobacterium Vaccae Has Been Given to Patients with Prostate Cancer and Melanoma Indicating a Possible Beneficial Effect on Disease Activity in Such Patients
British Journal of Cancer (2000) 83(7), 853–857 © 2000 Cancer Research Campaign doi: 10.1054/ bjoc.2000.1401, available online at http://www.idealibrary.com on A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma MER O’Brien1,2, A Saini1, IE Smith1, A Webb1, K Gregory1, R Mendes1,3, C Ryan2, K Priest1, KV Bromelow3, RD Palmer4, N Tuckwell6, DA Kennard5 and BE Souberbielle1,3 1Royal Marsden Hospital NHS Trust, Sutton, Surrey, SM2 5PT; 2Kent Cancer Centre, Maidstone, ME16 9QQ; 3Dept of Molecular Medicine, King’s College, SE5 9NU, London, 4Department of Bacteriology, University College London Medical School, W1P 6DB; 5SR Pharma, 26th Floor, Centre Point, 103 New Oxford Street, London WC1A 1DD, UK Summary Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a therapeutic vaccine derived from Mycobacterium vaccae has been given to patients with prostate cancer and melanoma indicating a possible beneficial effect on disease activity in such patients. We have recently initiated a series of randomized studies to test the feasibility and toxicity of combining a preparation of heat-killed Mycobacterium vaccae (designated SRL172) with a multidrug chemotherapy regimen to treat patients with inoperable non-small cell lung cancer (NSCLC) and mesothelioma. 28 evaluable patients with previously untreated symptomatic NSCLC and mesothelioma were randomized to receive either 3 weekly intravenous combination chemotherapy alone, or chemotherapy given with monthly intra-dermal injections of SRL172. Safety and tolerability were scored by common toxicity criteria and efficacy was evaluated by survival of patients and by tumour response assessed by CT scanning. -
Identification of Mycobacterium Avium Pathogenicity Island Important For
MICROBIOLOGY. For the article ‘‘Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection,’’ by Lia Danelishvili, Martin Wu, Bernadette Stang, Melanie Harriff, Stuart Cirillo, Jeffrey Cirillo, Robert Bildfell, Brian Arbogast, and Luiz E. Bermudez, which appeared in issue 26, June 26, 2007, of Proc Natl Acad Sci USA (104:11038– 11043; first published June 19, 2007; 10.1073͞pnas.0610746104), the author name Stuart Cirillo should have appeared as Suat L. G. Cirillo, and the author name Jeffrey Cirillo should have appeared as Jeffrey D. Cirillo. The online version has been corrected. The corrected author line appears below. Addition- ally, the present address for both these authors should be: Department of Microbial and Molecular Pathogenesis, Texas A&M University College of Medicine, College Station, TX 77843-1114. The authors also note that Fig. 1 did not print at high resolution. The corrected figure and its legend appear below. Lia Danelishvili, Martin Wu, Bernadette Stang, Melanie Harriff, Suat L. G. Cirillo, Jeffrey D. Cirillo, Robert Bildfell, Brian Arbogast, and Luiz E. Bermudez Fig. 1. Chromosome regions. (A) Organization of the chromosome region inactivated in the 8H8 clone of M. avium involved in the glycosylation of the lipopeptide core. (B) Organization of the chromosome region inactivated in the M. avium 9B9 clone. The M. avium gene names correspond to MAP numbers from the M. avium subsp. paratuberculosis genome sequence. (C) Genetic organization of M. avium 104 PI associated with low invasion of macrophages and virulence in mice. The M. avium 104 (b) sequence and gene organization of this region are presented in comparison with M. -
Pathogenicity of Mycobacterium Fortuitum and Mycobacterium Smegmatis to Goldfish, Carassius Auratus Adel M
Veterinary Microbiology 66 (1999) 151±164 Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus Adel M. Talaata,b,1, Michele Trucksisa,c, Andrew S. Kaneb, Renate Reimschuesselb,* aCenter for Vaccine Development, Division of Geographic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA bDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA cMedical Service, Veterans' Affairs Medical Center, Baltimore, MD 21201, USA Received 3 June 1998; accepted 22 December 1998 Abstract Despite the ubiquitous presence of atypical mycobacteria in the environment and the potential risk of infection in humans and animals, the pathogenesis of diseases caused by infection with atypical mycobacteria has been poorly characterized. In this study, goldfish, Carassius auratus were infected either with the rapidly growing fish pathogen, Mycobacterium fortuitum or with another rapidly growing mycobacteria, Mycobacterium smegmatis. Bacterial persistence and pathological host response to mycobacterial infection in the goldfish are described. Mycobacteria were recovered from a high percentage of inoculated fish that developed a characteristic chronic granulomatous response similar to that associated with natural mycobacterial infection. Both M. fortuitum and M. smegmatis were pathogenic to fish. Fish infected with M. smegmatis ATCC 19420 showed the highest level of giant cell recruitment compared to fish inoculated with M. smegmatis mc2155 and M. fortuitum. Of the three strains of mycobacteria examined, M. smegmatis ATCC 19420 was the most virulent strain to goldfish followed by M. fortuitum and M. smegmatis mc2155, respectively. # 1999 Elsevier Science B.V. All rights reserved. Keywords: Fish; Virulence; Mycobacteria; Mycobacterium fortuitum; Mycobacterium smegmatis; Pathogenesis * Corresponding author.